Antimicrobial Alcohol Hand

Alcohol


Geri-gentle Corporation
Human Otc Drug
NDC 69771-002
Antimicrobial Alcohol Hand also known as Alcohol is a human otc drug labeled by 'Geri-gentle Corporation'. National Drug Code (NDC) number for Antimicrobial Alcohol Hand is 69771-002. This drug is available in dosage form of Patch. The names of the active, medicinal ingredients in Antimicrobial Alcohol Hand drug includes Alcohol - 65.9 g/100g . The currest status of Antimicrobial Alcohol Hand drug is Active.

Drug Information:

Drug NDC: 69771-002
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Antimicrobial Alcohol Hand
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Alcohol
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Geri-gentle Corporation
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Patch
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:ALCOHOL - 65.9 g/100g
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: OTC MONOGRAPH NOT FINAL
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 05 Apr, 2017
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 25 Dec, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number: part333E
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Geri-Gentle Corporation
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
RxCUI:1251416
The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:3K9958V90M
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
69771-002-00135 PATCH in 1 CANISTER (69771-002-00) / 6.59 g in 1 PATCH05 Apr, 2017N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose antiseptic

Product Elements:

Antimicrobial alcohol hand alcohol water propylene glycol carboxypolymethylene trolamine aloe vera leaf .alpha.-tocopherol acetate edetate sodium alcohol alcohol

Indications and Usage:

Uses antiseptic for handwashing to decrease bacteria on the skin, assisting ill persons, and before contact with a person under medical care or treatment apply topically to the skin to help prevent cross-contamination recommended for repeated use dries in seconds

Warnings:

Warnings flammable, keep away from fire or flame for external use only do not use in or make contact with the eyes discontinue use if irritation and redness develop. if condition persists for more than 72 hours consult a physician keep this our of reach of children unless under adult supervision if swallowed, get medical help or contact a poison center immediately

Do Not Use:

Warnings flammable, keep away from fire or flame for external use only do not use in or make contact with the eyes discontinue use if irritation and redness develop. if condition persists for more than 72 hours consult a physician keep this our of reach of children unless under adult supervision if swallowed, get medical help or contact a poison center immediately

Dosage and Administration:

Directions to start feed: remove cover and discard seal from container. from center of toweled roll, pull up wipe corner, tear off fist wipe for use. twist next wipe into a point and thread through the hole in the container cover. pull through about one inch. replace cover. pull out wipes as needed and snap off at 90° angle. keep cap closed to prevent moisture loss wipe hands , fingers, interdigital areas and wrists thoroughly with towelette. be sure to utilize the entire wipe surface. allow to dry if hands are visibly soiled or contaminated, use first wipe to clean hands, then discard wipe, sanitize with a second wipe discard after single use

Package Label Principal Display Panel:

Package labeling: label 2


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.